Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 15, Number 1—January 2009

Letter

Linezolid-Resistant Staphylococcus cohnii, Greece

Efi PetinakiComments to Author , Maria Kanellopoulou, Anthi Damani, Antigoni Foka, Iris Spiliopoulou, Nikoletta Skalmoutsou, Bogdan Raitsiou, Konstantinos Valakis, and Evangelos Papafragas
Author affiliations: University of Thessalia, Larissa, Greece (E. Petinaki); Sismanoglion General Hospital of Athens, Athens, Greece (M. Kanellopoulou, N. Skalmoutsou, B. Raitsiou, K.Valakis, E. Papafragas); Institute of BioMedical Research and Technology, Larissa (E. Petinaki, A. Damani); University of Patras, Patras, Greece (A. Foka, I. Spiliopoulou)

Main Article

Table

Clinical characteristics of 4 patients from whom linezolid-resistant Staphylococcus cohnii was isolated, Greece, 2007*

Patient no. Gender/ age, y Medical
history Reason
for hospitalization Previous treatment Date of hospital admission Date of sample collection Outcome Date of death or discharge
1 F/82 No relevant history Acute cholecystitis, necrotizing pancreatitis CIP, CAZ, IMP, TZP, LIN May 10 Jul 20 Death Aug 21
2 M/38 Alcoholism Lung abscess CIP, CAZ, LIN Jul 14 Aug 21 Recovery Oct 20
3 M/52 COPD, melitensus diabetes Necrotizing pneumonia TZP, CLI, IMP, LIN Aug 21 Sep 25 Recovery Oct 30
4 M/65 No relevant history Septic shock IMP, CIP, TZP, LIN Sep 17 Oct 28 Recovery Dec 10

*CIP, ciprofloxacin; CAZ, ceftazidime; IMP, imipenem; TZP, piperacillin-tazobactam; LIN, linezolid; CLI, clindamycin; COPD, chronic obstructive pulmonary disease.

Main Article

TOP